SCHEMBL3531249

SCHEMBL3531249

CSc1ncnc2cc(OS(=O)(=O)C(F)(F)F)ccc12

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
HTR1D P28221 5/20 0.36
HTR1A P08908 4/20 0.36
HTR1B P28222 4/20 0.36
EGFR P00533 3/20 0.35
CXCR2 P25025 1/20 0.34
HSD11B1 P28845 1/20 0.34
DRD2 P14416 2/20 0.34
DRD3 P35462 2/20 0.34
CHRM1 P11229 1/20 0.34
DRD4 P21917 1/20 0.34
TRPA1 O75762 1/20 0.33
BRAF P15056 2/20 0.33
TNNI3K Q59H18 1/20 0.33
HTR2C P28335 1/20 0.33
HTR7 P34969 1/20 0.33
HTR6 P50406 1/20 0.33
CSF1R P07333 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3526766 0.79 KDM1A (0.45) EGFRBRAF
SCHEMBL15712195 0.76 ADORA2A (0.49) CA1CA2HTR1DHTR1AHTR1B
SCHEMBL19957320 0.71 CA1 (0.41) CA1CA2HTR1DHTR1AHTR1B
SCHEMBL7140629 0.70 EGFR (0.56) CA1CA2HTR1DHTR1AHTR1B
SCHEMBL3551410 0.68 HTR1A (0.46) HTR1A
SCHEMBL15712923 0.68 ADORA2A (0.49) CA1CA2HTR1DHTR1AHTR1B
SCHEMBL31731617 0.68 TLR8 (0.41) CA1CA2DRD2DRD3CHRM1
SCHEMBL30881095 0.68 HTR1D (0.39) CA1CA2HTR1DHTR1AHTR1B
SCHEMBL3528078 0.67 EGFR (0.47) HTR1AEGFRDRD3BRAFTNNI3K
SCHEMBL4420762 0.67 RET (0.43) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7709479-B1 Quinazoline derivatives and their use as pharmaceuticals ASTRAZENECA (SE) 2010-05-04 US disclosed
EP-1218354-A1 QUINAZOLINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS AstraZeneca AB (SE) 2002-07-03 EP disclosed
WO-2001021596-A1 QUINAZOLINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS ASTRAZENECA AB (SE) 2001-03-29 WO disclosed